Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen.
作者信息
Rao V S, Bonavida B, Zighelboim J, Fahey J L
出版信息
Transplantation. 1974 Jun;17(6):568-75. doi: 10.1097/00007890-197406000-00004.
Abstract
摘要
相似文献
1
Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen.可溶性同种异体抗原对血清封闭活性的优先诱导及皮肤同种异体移植的增强作用。
Transplantation. 1974 Jun;17(6):568-75. doi: 10.1097/00007890-197406000-00004.
2
Modulation of the immune response toward allografts in vivo. I. Selective suppression of the development of cell-mediated immunity by soluble alloantigens.体内对同种异体移植物免疫反应的调节。I. 可溶性同种异体抗原对细胞介导免疫发育的选择性抑制。
Cell Immunol. 1974 Jul;13(1):52-65. doi: 10.1016/0008-8749(74)90226-3.
3
T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.体外诱导的T细胞介导的免疫反应：同种异体移植和肿瘤免疫的一种检测方法。
Transplant Rev. 1973;17(0):3-36. doi: 10.1111/j.1600-065x.1973.tb00122.x.
4
Prolongation of skin allograft survival with antilymphocyte serum and soluble histocompatibility antigens.抗淋巴细胞血清和可溶性组织相容性抗原延长皮肤同种异体移植物存活时间
Transplantation. 1974 Jan 1;17(1):1-7. doi: 10.1097/00007890-197401000-00001.
5
Enhancement of skin allograft survival by soluble alloantigen is serum-mediated.
Transplantation. 1976 Jan;21(1):42-50. doi: 10.1097/00007890-197601000-00008.
6
Soluble transplantation antigens. Further studies of their tolerogenic properties.
Transplantation. 1974 Dec;18(6):487-95. doi: 10.1097/00007890-197412000-00003.
7
Blocking of syngeneic effector T cells by soluble tumour antigens.可溶性肿瘤抗原对同基因效应T细胞的阻断作用。
Nature. 1974 May 17;249(454):271-4. doi: 10.1038/249271a0.
8
9
10
New alloantigen genetically linked to the major histocompatibility locus of the mouse.与小鼠主要组织相容性位点基因连锁的新同种异体抗原。
Nature. 1974 Jul 19;250(463):228-30. doi: 10.1038/250228a0.
引用本文的文献
1
A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.一种由免疫原性和非免疫原性小鼠肿瘤共享的伴随抗性的血清介导机制。
Br J Cancer. 1996 Jul;74(2):178-86. doi: 10.1038/bjc.1996.335.
2
Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens.用H-2和非H-2同种异体抗原在体内激活自然杀伤（NK）细胞。
Immunogenetics. 1981;12(3-4):221-35. doi: 10.1007/BF01561666.
Zotero 插件